The USAID-funded program I work on, called Act to End Neglected Tropical Diseases (NTDs) | West, helps 11 countries in West Africa to control and eliminate neglected tropical diseases (NTDs) through a strategy known as mass drug administration (MDA). Although the medicines distributed through MDA are mainly tablets, not injections that require a cold chain, the challenges aren’t all that different from those facing COVID-19 vaccine campaigns: community-wide distribution of medicine—or several medicines, in the case of NTDs—to large numbers of people as the primary intervention.
USAID Publishes Technical Brief to Accompany New WHO Morbidity Management Tool for Lymphatic Filariasis Care
In March 2021, the USAID Neglected Tropical Diseases (NTD) Division and its Act to End NTDs | West and | East Programs, respectively managed by FHI 360 and RTI International, published a technical brief to complement World Health Organization’s (WHO) publication and share the experiences and key learnings of 12 National NTD Programs on their use of these tools.
By bringing critical stakeholders together to establish a shared understanding of the barriers to NTD progress, agree on the need for collaboration, and coordinate action to continue toward NTD control and elimination, Ghana's sensitization meeting served as a catalyst for ramping up progress toward NTD sustainability in Ghana.
On January 30, 2021, countries across West Africa brought awareness to neglected tropical diseases (NTDs) and the devastating effects they have on communities by celebrating the second annual World NTD Day.
January 30th is the second annual World Neglected Tropical Disease Day. Over one billion of the world’s poorest, most marginalized people are affected by neglected tropical diseases (NTDs), which often cause debilitating pain, illness, and lifelong disabilities. These diseases trap people in poverty and make it impossible for them to work, learn, or care for their families.
On October 8, 2020, Dr. Soro Kountelegona, Chief of Staff of the Ministry of Health of Côte d’Ivoire, did something that represents a milestone in the fight against neglected tropical diseases (NTDs) in West Africa. He convened a high-level meeting of representatives of various ministries in the Government of Côte d’Ivoire’s cabinet and presented a draft of the 2021–2023 national neglected tropical diseases sustainability plan to the cabinet as well as international and other national stakeholders for political validation, endorsement, and adoption.
What does it take to distribute almost 20 million pills to over 4.4 million people in just 14 days? Planning, training, and mobilization of thousands of community drug distributors (CDDs)—key elements that programs targeting neglected tropical diseases (NTDs) must organize in a typical year. But this is not a typical year.
FHI 360’s Kisito Ogoussan Begins Term as 2020–2021 Chair of Neglected Tropical Diseases NGO Network (NNN)
The close of the #NNN2020 annual conference, titled Accelerating to 2030: Building Resilient NTD Programmes in a Changing World, marked a changing of the guard in the Neglected Tropical Diseases (NTDs) NGO Network (NNN). On September 10, 2020, FHI 360’s Kisito Ogoussan became the 2020–2021 NNN chair, after serving as vice chair the previous year. As Dr. Ogoussan assumed his new position from the previous chair, Helen Keller International’s (HKI) Yaobi Zhang (who will now serve on the executive committee as immediate past chair), World Vision’s Arielle Dolegui simultaneously stepped into her new role as 2020–2021 NNN vice chair.
Benin’s Campaign Like No Other: Mass Treatment for Neglected Tropical Diseases during the COVID-19 Pandemic
Although preparations had been underway for weeks, there were now just 72 hours to go before the 2020 mass drug administration (MDA) treatment campaign for two neglected tropical diseases (NTDs)—lymphatic filariasis (LF) and onchocerciasis—would begin in the four geographic areas (called communes) of Ouinhi, Covè, Zagnanado, and Za-Kpota—and the tension was almost palpable.
L’OMS PRESENTE LES CONSIDÉRATIONS RELATIVES À LA MISE EN ŒUVRE DE TRAITEMENT DE MASSE, DE RECHERCHE ACTIVE DE CAS ET D'ENQUÊTES COMMUNAUTAIRE POUR LES MALADIES TROPICALES NÉGLIGÉES DANS LE CONTEXTE DE LA PANDÉMIE DE COVID-19.
Le 27 juillet 2020, l'Organisation mondiale de la santé (OMS) a publié un nouveau document intitulé "Considérations relatives à la mise en œuvre de traitement de masse, de la recherche active de cas et des enquêtes communautaires pour les maladies tropicales négligées dans le contexte de la pandémie COVID-19", qui contient un cadre décisionnel pour le traitement de masse des maladies tropicales négligées (MTN), la recherche de cas et les enquêtes en population dans le contexte COVID-19.